Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus

To investigate whether the Fibrosis‐4 index can help stratify the risk of diabetes mellitus in patients with fatty liver disease.

[1]  A. Sanyal,et al.  An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  K. Chayama,et al.  Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 , 2021, Journal of Gastroenterology.

[3]  V. Wong,et al.  Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis , 2021, Gut.

[4]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.

[5]  J. Tanabe,et al.  FIB-4 index is a marker for a subsequent decrease in insulin secretion in a non-diabetic Japanese population , 2020, Scientific Reports.

[6]  R. Andrade,et al.  Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. , 2020, Journal of hepatology.

[7]  S. Wild,et al.  Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  T. Okanoue,et al.  Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients , 2018, Journal of Gastroenterology.

[9]  Y. Hiasa,et al.  Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study , 2018, PloS one.

[10]  O. Weiland,et al.  Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication. , 2017, Journal of hepatology.

[11]  Y. Hiasa,et al.  Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels , 2017, Journal of Gastroenterology.

[12]  T. Maddox,et al.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. , 2015, World journal of diabetes.

[13]  E. Bjornsson,et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[14]  Y. Hiasa,et al.  Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion , 2015, Journal of Gastroenterology.

[15]  S. Wild,et al.  Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes , 2012, Diabetes Care.

[16]  T. Joh,et al.  Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup , 2010, Journal of gastroenterology and hepatology.

[17]  K-U. Lee,et al.  Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[18]  A. Feldstein,et al.  Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future , 2007, Hepatology.

[19]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[20]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[21]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[22]  D. Joy,et al.  Diagnosis of fatty liver disease: is biopsy necessary? , 2003, European journal of gastroenterology & hepatology.

[23]  A. Holstein,et al.  Clinical implications of hepatogenous diabetes in liver cirrhosis , 2002, Journal of gastroenterology and hepatology.

[24]  E Mervaala,et al.  Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[25]  Shohei Matsuzaki,et al.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background , 2003, Journal of Gastroenterology.